G. Eisenhofer

G. Eisenhofer received his Ph.D. degree in 1983 from the University of Otago, Otago, New Zealand. After completing his postdoctoral studies at the National Institutes of Health (NIH), he moved to the Baker Heart Research Institute in Melbourne, Australia, where he continued his research on sympathetic nerve function in health and disease. He returned to the NIH in 1991 as Head of the Clinical Neurochemistry Unit at the National Institutes of Neurological Disorders and Stroke before taking up a Professorship in the Institute of Clinical Chemistry and Laboratory Medicine and the Department of Medicine at the University Hospital in Dresden, Germany. Eisenhofer’s research experience covers both basic and patient-oriented research, with emphasis on clinical studies involving catecholamine systems. Most recently this research has focused on neuroendocrine tumors, in particular pheochromocytoma. Relevant achievements in that area include development of measurements of plasma-free metanephrines as an improved biochemical test for diagnosis of pheochromocytoma and of 18F-fluorodopamine as a positron emission tomographic imaging agent for visualizing sympathetic nerves and neuroendocrine tumors.

Biography Updated on 26 December 2010

Scholarly Contributions [Data Provided by ]